Moderna and Pfizer's Second-Gen Coronavirus Vaccines: What Investors Need to KnowThe Motley Fool • 03/07/21
How Worried Should Investors Be About the South African Coronavirus Variant?The Motley Fool • 03/06/21
Pfizer's Plant For Boosting COVID-19 Vaccine Production Has Been Rebuked For Repeat Quality Offenses: BloombergBenzinga • 03/05/21
Why the FDA's Coronavirus Variant Guidance Is Great News for Pfizer, Moderna, and Johnson & JohnsonThe Motley Fool • 03/05/21
Pfizer (PFE) Down 1.3% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/04/21
Pfizer's Lorbrena Wins Full FDA Approval As First Line Treatment Of ALK-Positive Lung CancerBenzinga • 03/04/21
U.S. FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung CancerBusiness Wire • 03/04/21
Pfizer and AstraZeneca vaccines 'highly effective' at preventing hospital admissions in over-80sSkynews • 03/03/21
Real-world data shows Pfizer's Covid vaccine is giving 'very strong' results after one doseCNBC • 03/02/21
Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by up to 80%, study showsMarket Watch • 03/02/21
Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma PartnerPRNewsWire • 03/02/21